
RA-9
CAS No. 919091-63-7
RA-9 ( —— )
产品货号. M22045 CAS No. 919091-63-7
RA-9 是一种有效的、选择性的蛋白酶体相关去泛素化酶 (DUB) 抑制剂,具有良好的毒性和抗癌活性。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥365 | 有现货 |
![]() ![]() |
10MG | ¥616 | 有现货 |
![]() ![]() |
25MG | ¥1077 | 有现货 |
![]() ![]() |
50MG | ¥1596 | 有现货 |
![]() ![]() |
100MG | ¥2495 | 有现货 |
![]() ![]() |
200MG | 获取报价 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称RA-9
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述RA-9 是一种有效的、选择性的蛋白酶体相关去泛素化酶 (DUB) 抑制剂,具有良好的毒性和抗癌活性。
-
产品描述RA-9 is a potent and selective proteasome-associated inhibitor of deubiquitinating enzymes (DUBs), with favorable toxicity profile and anticancer activity. RA-9 selectively induces apoptosis in ovarian cancer cell lines.The characterization of RA-9 as a small-molecule inhibitor of proteasome-associated DUBs.?Treatment with RA-9 selectively induces onset of apoptosis in ovarian cancer cell lines and primary cultures derived from donors.?Loss of cell viability following RA-9 exposure is associated with an unfolded protein response as mechanism to compensate for unsustainable levels of proteotoxic stress.?In vivo treatment with RA-9 retards tumor growth, increases overall survival, and was well tolerated by the host.
-
体外实验Cell Viability Assay Cell Line:Cisplatin-sensitive ovarian cancer cell lines TOV-21G and ES-2, Cisplatin-resistant ovarian cancer cell lines HEY and OVCAR-3, primary ovarian cancer cellsConcentration:10, 20, 30 μM Incubation Time:48 hours Result:Compromised the viability of ovarian cancer cells in a dose-dependent fashion.Cell Cycle Analysis Cell Line:ES-2 cells Concentration:1.25, 5 μM Incubation Time:18 hours Result:Resulted in a dose-dependent increase in the fraction of ES-2 cells in the G2-M cell cycle phase.Western Blot Analysis Cell Line:ES-2, SKOV-3 and TOV-21G ovarian cancer cells Concentration:5 μM Incubation Time:0-24 h Result:Caused a time-dependent increase in the steady levels of the early ER-stress marker GRP-78, as well as the late ER-stress markers IRE1-α and Ero1L-α.
-
体内实验Animal Model:Six-week-old female immunodeficient (NCr nu/nu) mice Dosage:5 mg/kg Administration:I.p; one-day on, two-days off Result:Significant reduction in tumor burden at day 12.
-
同义词——
-
通路Apoptosis
-
靶点Apoptosis
-
受体Apoptosis|deubiquitinating enzymes (DUBs)
-
研究领域——
-
适应症——
化学信息
-
CAS Number919091-63-7
-
分子量365.34
-
分子式C19H15N3O5
-
纯度>98% (HPLC)
-
溶解度DMSO:4 mg/mL (10.95 mM; ultrasonic and warming and heat to 80°C)
-
SMILES[O-][N+](=O)c1ccc(\C=C2/CNC\C(=C/c3ccc(cc3)[N+]([O-])=O)C2=O)cc1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Coughlin K , Anchoori R , Iizuka Y , et al. Small-molecule RA-9 inhibits proteasome-associated DUBs and ovarian cancer in vitro and in vivo via exacerbating unfolded protein responses.[J]. Clinical Cancer Research An Official Journal of the American Association for Cancer Research, 2014, 20(12):3174-86.
产品手册




关联产品
-
Ceranib-2
Ceranib-2 是一种神经酰胺酶抑制剂,在 SKOV3 细胞中的 IC50 为 28 μM。
-
NBDHEX
NBDHEX 是谷胱甘肽 S-转移酶 P1-1 (GSTP1-1) 的有效抑制剂。
-
BTM-3528
BTM-3528 是线粒体蛋白酶 OMA1 的激活剂,介导线粒体整合应激反应 (ISR) 的过度激活。BTM-3528 刺激 OMA1 依赖性 DELE1 和 OPA1 裂解、线粒体断裂。BTM-3528 激活 eIF2α 激酶 HRI,诱导细胞生长停滞和细胞凋亡 (apoptosis)。BTM-3528 对多种 DLBCL 细胞系具有抗癌活性,在异种移植人 DLBCL SU-DHL-10 细胞的小鼠模型中具有体内抑制效力。